Literature DB >> 19549587

Non-genomic regulation of vascular cell function and growth by estrogen.

Matthias R Meyer1, Elvira Haas, Eric R Prossnitz, Matthias Barton.   

Abstract

Estrogens exert rapid, non-genomic effects, which are mediated by plasma membrane-associated estrogen receptors (mER) mERalpha and mERbeta, and the intracellular transmembrane G protein-coupled estrogen receptor (GPER). Membrane-initiated responses contribute to transcriptional activation, resulting in a complex interplay of nuclear and extra-nuclear mechanisms that mediate the acute physiological responses to estrogens. Non-genomic estrogen signaling also activates a variety of intracellular estrogen signaling pathways that regulate vascular function and cell growth involving rapid but also long-term effects. This review discusses recent advances in understanding of the mechanisms of non-genomic estrogen receptor signaling in the vascular wall.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549587      PMCID: PMC2780565          DOI: 10.1016/j.mce.2009.03.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  99 in total

1.  Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α .

Authors:  Premlata Kumar; Qian Wu; Ken L Chambliss; Ivan S Yuhanna; Susanne M Mumby; Chieko Mineo; Gregory G Tall; Philip W Shaul
Journal:  Mol Endocrinol       Date:  2007-04-03

Review 2.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

3.  Inhibition of estrogen-induced cyclic AMP elevation in rat uterus. II: By glucocorticoids.

Authors:  C M Szego; J S Davis
Journal:  Life Sci       Date:  1969-10-01       Impact factor: 5.037

4.  Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.

Authors:  James G Greger; Natalie Fursov; Neil Cooch; Sean McLarney; Leonard P Freedman; Dean P Edwards; Boris J Cheskis
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

5.  Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway.

Authors:  Tommaso Simoncini; Camila Scorticati; Paolo Mannella; Ahmed Fadiel; Maria S Giretti; Xiao-Dong Fu; Chiara Baldacci; Silvia Garibaldi; Antonella Caruso; Letizia Fornari; Frederick Naftolin; Andrea R Genazzani
Journal:  Mol Endocrinol       Date:  2006-04-06

6.  Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha.

Authors:  Qing Lu; David C Pallas; Howard K Surks; Wendy E Baur; Michael E Mendelsohn; Richard H Karas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

7.  The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.

Authors:  Adele Vivacqua; Daniela Bonofiglio; Anna Grazia Recchia; Anna Maria Musti; Didier Picard; Sebastiano Andò; Marcello Maggiolini
Journal:  Mol Endocrinol       Date:  2005-10-20

Review 8.  Endothelium-derived hyperpolarizing factor: where are we now?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-16       Impact factor: 8.311

9.  Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice.

Authors:  Ulrika E A Mårtensson; S Albert Salehi; Sara Windahl; Maria F Gomez; Karl Swärd; Joanna Daszkiewicz-Nilsson; Anna Wendt; Niklas Andersson; Per Hellstrand; Per-Olof Grände; Christer Owman; Clifford J Rosen; Martin L Adamo; Ingmar Lundquist; Patrik Rorsman; Bengt-Olof Nilsson; Claes Ohlsson; Björn Olde; L M Fredrik Leeb-Lundberg
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

10.  Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.

Authors:  Peter Collins; Lori Mosca; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Messan G Amewou-Atisso; Mark B Effron; Sherie A Dowsett; Elizabeth Barrett-Connor; Nanette K Wenger
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

View more
  49 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.

Authors:  Han Liu; Ali Pedram; Jin Kyung Kim
Journal:  Cardiovasc Res       Date:  2010-08-19       Impact factor: 10.787

3.  Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Authors:  Isabella Baruscotti; Federica Barchiesi; Edwin K Jackson; Bruno Imthurn; Ruth Stiller; Jai-Hyun Kim; Sara Schaufelberger; Marinella Rosselli; Christopher C W Hughes; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

4.  Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males.

Authors:  Adriana Laser; Abhijit Ghosh; Karen Roelofs; Omar Sadiq; Brendan McEvoy; Paul DiMusto; Jon Eliason; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2013-08-18       Impact factor: 2.192

Review 5.  The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview.

Authors:  Tao Luo; Jin Kyung Kim
Journal:  Can J Cardiol       Date:  2015-11-02       Impact factor: 5.223

Review 6.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

7.  Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).

Authors:  Nilfer Sahin; Hatice Altun; Ergül Belge Kurutaş; Ebru Fındıklı
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

8.  Increased PELP1 expression in rat periodontal ligament tissue in response to estrogens treatment.

Authors:  Jing Wang; Qiang Zhu; Shujun Song; Jun Dong; Lixin Shi; Ran Tao; Yin Ding; Baofa Hong
Journal:  J Mol Histol       Date:  2013-02-24       Impact factor: 2.611

Review 9.  Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-13       Impact factor: 3.072

Review 10.  Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation.

Authors:  Matthias Barton; Matthias R Meyer; Eric R Prossnitz
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.